Splicing modifier made to handle SMA brought on by mutations in chromosome 5q that result in survival motor neuron (SMN) protein deficiency. Evrysdi is administered daily in your house in liquid kind by mouth or by feeding tube. Risdiplam, an SMN2 splicing modifier, is at the moment the one orally https://stevenz963mrx6.blogrenanda.com/profile